These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19297207)

  • 1. Whole-body MR angiography with body coil acquisition at 3 T in patients with peripheral arterial disease using the contrast agent gadofosveset trisodium.
    Nielsen YW; Eiberg JP; Løgager VB; Hansen MA; Schroeder TV; Thomsen HS
    Acad Radiol; 2009 Jun; 16(6):654-61. PubMed ID: 19297207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body magnetic resonance angiography with additional steady-state acquisition of the infragenicular arteries in patients with peripheral arterial disease.
    Nielsen YW; Eiberg JP; Løgager VB; Just S; Schroeder TV; Thomsen HS
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):484-91. PubMed ID: 19957180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body MR angiography in patients with peripheral arterial disease.
    Nielsen YJ
    Dan Med Bull; 2010 Dec; 57(12):B4231. PubMed ID: 21122468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine.
    Klessen C; Hein PA; Huppertz A; Voth M; Wagner M; Elgeti T; Kroll H; Hamm B; Taupitz M; Asbach P
    Invest Radiol; 2007 Sep; 42(9):659-64. PubMed ID: 17700282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic blood pool contrast agent-enhanced whole-body MR angiography for treatment planning in patients with significant arterial stenosis.
    Huppertz A; Kroll H; Klessen C; Taupitz M; Rückert RI; Schröder RJ; Albrecht T; Frericks B; Voth M; Wagner M; Hamm B; Asbach P
    Invest Radiol; 2009 Jul; 44(7):422-32. PubMed ID: 19448555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body magnetic resonance angiography at 3 tesla using a hybrid protocol in patients with peripheral arterial disease.
    Nielsen YW; Eiberg JP; Logager VB; Schroeder TV; Just S; Thomsen HS
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):877-86. PubMed ID: 19296155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR angiography of infrapopliteal arteries in patients with peripheral arterial occlusive disease by using Gadofosveset at 3.0 T: diagnostic accuracy compared with selective DSA.
    Bonel HM; Saar B; Hoppe H; Keo HH; Husmann M; Nikolaou K; Ludwig K; Szucs-Farkas Z; Srivastav S; Kickuth R
    Radiology; 2009 Dec; 253(3):879-90. PubMed ID: 19864508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body MR angiography: first experiences with the new TimCT technology with single contrast injection.
    Naguib NN; Bohrt K; Nour-Eldin NE; Schulz B; Tawfik AM; Siebenhandel P; Bodelle B; Eichler K; Moritz A; Vogl TJ; Zangos S
    J Magn Reson Imaging; 2014 Feb; 39(2):434-9. PubMed ID: 23681601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging the whole body atherosclerosis: high resolution magnetic resonance angiography using blood-pool agent. Initial clinical experience.
    Napoli A; Catalano C; Anzidei M; Lanciotti K; Calabrese FA; Cavallo Marincola B; Zini C; Di Paolo PL; Kyventidis T; Passariello R
    Minerva Cardioangiol; 2007 Jun; 55(3):291-301. PubMed ID: 17534247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced MRA of the renal and aorto-iliac-femoral arteries: comparison of gadobenate dimeglumine and gadofosveset trisodium.
    Iezzi R; Soulez G; Thurnher S; Schneider G; Kirchin MA; Shen N; Pirovano G; Spinazzi A
    Eur J Radiol; 2011 Feb; 77(2):358-68. PubMed ID: 19679417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gadofosveset-enhanced three-dimensional magnetic resonance angiography with digital subtraction angiography for lower-extremity peripheral arterial occlusive disease.
    Grijalba FU; Esandi MC
    Acta Radiol; 2010 Apr; 51(3):284-9. PubMed ID: 20105092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of systemic arterial diseases with whole-body 3D contrast-enhanced magnetic resonance angiography.
    Lin J; Chen B; Wang JH
    Chin Med J (Engl); 2006 Nov; 119(21):1772-8. PubMed ID: 17097030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study.
    Rapp JH; Wolff SD; Quinn SF; Soto JA; Meranze SG; Muluk S; Blebea J; Johnson SP; Rofsky NM; Duerinckx A; Foster GS; Kent KC; Moneta G; Middlebrook MR; Narra VR; Toombs BD; Pollak J; Yucel EK; Shamsi K; Weisskoff RM
    Radiology; 2005 Jul; 236(1):71-8. PubMed ID: 15987963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of contrast-enhanced MR angiography to intraarterial digital subtraction angiography for evaluation of peripheral arterial occlusive disease: results of a phase III multicenter trial.
    Bui BT; Miller S; Mildenberger P; Sam A; Sheng R;
    J Magn Reson Imaging; 2010 Jun; 31(6):1402-10. PubMed ID: 20512893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic performance of contrast-enhanced MR angiography of the aortoiliac arteries with the blood pool agent Vasovist: initial results in comparison to intra-arterial DSA].
    Vogt FM; Herborn CU; Parsons EC; Kröger K; Barkhausen J; Goyen M
    Rofo; 2007 Apr; 179(4):412-20. PubMed ID: 17385136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of peripheral contrast-enhanced magnetic resonance angiography at 3.0 Tesla with a hybrid technique: comparison with digital subtraction angiography.
    Berg F; Bangard C; Bovenschulte H; Hellmich M; Nijenhuis M; Lackner K; Gossmann A
    Invest Radiol; 2008 Sep; 43(9):642-9. PubMed ID: 18708858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of a high-resolution whole-body MR angiography protocol with parallel imaging and biphasic administration of a single bolus of Gd-BOPTA: preliminary experience in the systemic evaluation of atherosclerotic burden in patients referred for endovascular procedures.
    Napoli A; Anzidei M; Marincola BC; Zaccagna F; Geiger D; Di Paolo PL; Zini C; Catalano C; Passariello R
    Radiol Med; 2009 Jun; 114(4):538-52. PubMed ID: 19430733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.
    Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF
    Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
    Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
    Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR angiography of the pedal arteries with gadobenate dimeglumine, a contrast agent with increased relaxivity, and comparison with selective intraarterial DSA.
    Kreitner KF; Kunz RP; Herber S; Martenstein S; Dorweiler B; Dueber C
    J Magn Reson Imaging; 2008 Jan; 27(1):78-85. PubMed ID: 18058929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.